Key facts
- It has raised $1.4M; the latest was Early Stage VC ($1.4M) in Dec 2024.
- Notable investors include Tamarace Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Huachuang Shenting
- ·The full record, as it builds
Funding rounds
No funding rounds for Huachuang Shenting are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Huachuang Shenting
Developer of AI detection designed for the cranium. The company's products mainly focus on brain health AI detection technology research and development, which can be applied in clinical departments such as neurology, neurosurgery, ICU, pediatrics, PICU, emergency department, geriatrics, etc., providing customers with reliable and innovative products.
- Sector
- Healthcare
- HQ
- Chongqing, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Huachuang Shenting doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Huachuang Shenting shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Huachuang Shenting in its N-PORT filings yet. We sweep new filings monthly.